gilead sciences inc (GILD:NASDAQ GS)
Joel Huff Ph.D.
Chairperson of Scientific Advisory Board, Gilead Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 42 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Joel Huff, Ph.D. served as Vice President of Medicinal Chemistry at Merck Research Laboratories until 2004, following 30 years of service. Dr. Huff serves as a Member of the Scientific Advisory Board of Epizyme, Inc. At Merck he led efforts to develop therapeutic agents for HIV, resulting in the discovery of indianvir (Crixivan®), and efavirenz (Stocrin®, Sustiva®). Dr. Huff serves as the Chairperson of Scientific Advisory Board at Gilead Sciences Inc. Dr. Huff has ...
333 Lakeside DrivePhone: 650-574-3000
Foster City, California 94404
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
The University of Texas, Austin
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|